Compound ID | 2381
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Disrupts integrity of the outer membrane in Gram-negative |
| Target Pathogen: | Active against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa |
| Description: | Synthetic compound; a cationic amphiphile; potentiates rifampicin, novobiocin, erythromycin, and linezolid |
| Year first mentioned: | 2021 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://pubs.acs.org/doi/10.1021/acschembio.1c00179 |